Chromogranin A as Serum Marker for Neuroendocrine Neoplasia: Comparison with Neuron-Specific Enolase and the α-Subunit of Glycoprotein Hormones
Frank Nobels(Rotterdam University of Applied Sciences), Steven W. J. Lamberts(Erasmus MC), Wouter W. de Herder(Erasmus University Rotterdam), Roger Bouillon(KU Leuven), Dik J. Kwekkeboom(Erasmus MC), Eric P. Krenning(Erasmus MC), C.H.H. Schoenmakers(Rotterdam University of Applied Sciences), Willy Coopmans, Jan Lindemans(Uppsala University Hospital)
Cited by 353
Related Papers
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Treatment With the Radiolabeled Somatostatin Analog [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate: Toxicity, Efficacy, and Survival
|Journal of Clinical Oncology|2008|1.4k
Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions
|Endocrine Reviews|2018|1.1k